Detalhe da pesquisa
1.
IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans.
Infect Immun
; 92(2): e0050423, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193711
2.
Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages.
Genes Immun
; 23(2): 73-84, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115664
3.
Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model.
Cancer Immunol Immunother
; 69(9): 1725-1735, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328672
4.
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
Antimicrob Agents Chemother
; 55(4): 1661-70, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220536
5.
Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes.
J Leukoc Biol
; 110(2): 357-374, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205487
6.
Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses.
J Immunol
; 181(2): 1386-98, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18606693
7.
A peptide-modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model.
Biomater Sci
; 7(3): 1161-1178, 2019 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652182
8.
A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes.
Mol Ther Nucleic Acids
; 10: 9-27, 2018 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29499959